Form D · Other Health Care
Cosmos Pharmaceuticals, Inc.
Middletown, DE · CIK 0001845816
Offering snapshot reported Oct 7, 2025 · SEC filing
- Reported sold
- $750K Offering amount: $1.25M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 22, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 7, 2025 | Initial | $750,000 | No comparison | 14 | SEC filing |
| Jun 3, 2022 | Initial | $175,000 | No comparison | 7 | SEC filing |
| Feb 23, 2021 | Initial | $225,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-559998
Source: Form D, filed Oct 7, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alexander M. Colton | Director, Executive |
| Christian Colton | Director |
| Bart Edmunds | Director |
| Philip Mc Bride | Executive |
| Joseph W. White | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
537 Wheelmen Street
Middletown, DE, 19709
Middletown, DE, 19709